Your browser doesn't support javascript.
loading
Type I IFN protects cancer cells from CD8+ T cell-mediated cytotoxicity after radiation.
Chen, Jianzhou; Cao, Yunhong; Markelc, Bostjan; Kaeppler, Jakob; Vermeer, Jenny Af; Muschel, Ruth J.
Affiliation
  • Chen J; CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom.
  • Cao Y; Department of Radiation Oncology, Cancer Hospital of Shantou University Medical College, Shantou, China.
  • Markelc B; CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom.
  • Kaeppler J; CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom.
  • Vermeer JA; CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom.
  • Muschel RJ; CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom.
J Clin Invest ; 129(10): 4224-4238, 2019 10 01.
Article in En | MEDLINE | ID: mdl-31483286
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interferon Type I / CD8-Positive T-Lymphocytes Language: En Journal: J Clin Invest Year: 2019 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interferon Type I / CD8-Positive T-Lymphocytes Language: En Journal: J Clin Invest Year: 2019 Document type: Article